Literature DB >> 18455314

Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse.

Theodore J Cicero1, Michael Lynskey, Alexandre Todorov, James A Inciardi, Hilary L Surratt.   

Abstract

The purpose of this study was to identify co-morbidity in a national sample (N=1408) of males and females entering treatment for opioid abuse. Our sample was primarily white, lived in small urban, suburban or rural locations (80%), and was well-educated. Chronic pain was a symptomatic feature in over 60% of all subjects. Furthermore, 79% of male and 85% of female prescription opioid abusers indicated that their first exposure to an opioid was a legitimate prescription for pain which subsequently led 60-70% to misuse to get high. Our data also indicate that the use of prescription opioids to get high represents the end stage on a continuum of substance abuse, beginning at a very early age. The age of first alcohol use, getting drunk, smoking, use of marijuana, stimulants and other non-opioid prescription or illicit drugs occurred very early (13-19) in prescription opioid misusers/abusers, whose first use of opioids did not occur, on average, until age 22. Finally, most of the sample had sought treatment 3 or more times for substance abuse prior to the treatment admission in which the survey was completed. Physical and mental health were very poor in both male and female prescription opioid abusers, but females were more ill and dysfunctional than males in all physical and particularly emotional domains. Our results suggest that a small number of "at risk" opioid naive pain patients, who might abuse their therapeutically appropriate opioid analgesics, can be identified by assessing pre- and co-morbid substance abuse and significant psychopathology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18455314     DOI: 10.1016/j.pain.2008.03.021

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  51 in total

1.  [Life-threatening fentanyl and propofol addiction: interview with a survivor].

Authors:  C Maier; J Leclerc-Springer
Journal:  Anaesthesist       Date:  2012-07       Impact factor: 1.041

2.  Patterns of prescription opioid abuse and comorbidity in an aging treatment population.

Authors:  Theodore J Cicero; Hilary L Surratt; Steven Kurtz; M S Ellis; James A Inciardi
Journal:  J Subst Abuse Treat       Date:  2011-08-09

3.  OxyContin use on a rural midwest American Indian reservation: demographic correlates and reasons for using.

Authors:  Sandra L Momper; Jorge Delva; Debbie Tauiliili; Amelia Cromwell Mueller-Williams; Patricia Goral
Journal:  Am J Public Health       Date:  2013-09-12       Impact factor: 9.308

4.  Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial.

Authors:  Robert N Jamison; Edgar L Ross; Edward Michna; Li Q Chen; Caroline Holcomb; Ajay D Wasan
Journal:  Pain       Date:  2010-03-23       Impact factor: 6.961

5.  Clinical correlates of prescription opioid analgesic use in pregnancy.

Authors:  Megan V Smith; Darce Costello; Kimberly A Yonkers
Journal:  Matern Child Health J       Date:  2015-03

6.  Longitudinal association between pain severity and subsequent opioid use in prescription opioid dependent patients with chronic pain.

Authors:  Margaret L Griffin; Katherine A McDermott; R Kathryn McHugh; Garrett M Fitzmaurice; Robert N Jamison; Roger D Weiss
Journal:  Drug Alcohol Depend       Date:  2016-04-25       Impact factor: 4.492

7.  Tamper-resistant drugs cannot solve the opioid crisis.

Authors:  Pamela Leece; Aaron M Orkin; Meldon Kahan
Journal:  CMAJ       Date:  2015-06-29       Impact factor: 8.262

8.  Prevalence and experience of chronic pain in suburban drug injectors.

Authors:  Robert Heimer; Weihai Zhan; Lauretta E Grau
Journal:  Drug Alcohol Depend       Date:  2015-03-19       Impact factor: 4.492

9.  Gender and prescription opioid misuse in the emergency department.

Authors:  Esther K Choo; Carole Douriez; Traci Green
Journal:  Acad Emerg Med       Date:  2014-12       Impact factor: 3.451

Review 10.  Medical and psychological risks and consequences of long-term opioid therapy in women.

Authors:  Beth D Darnall; Brett R Stacey; Roger Chou
Journal:  Pain Med       Date:  2012-08-20       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.